These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29660567)

  • 1. Summary of expression of SPARC protein in cutaneous vascular neoplasms and mimickers.
    Mauzo SH; Milton DR; Prieto VG; Torres-Cabala CA; Wang WL; Chakravarti N; Nagarajan P; Tetzlaff MT; Curry JL; Ivan D; Brown RE; Aung PP
    Ann Diagn Pathol; 2018 Jun; 34():151-154. PubMed ID: 29660567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cells in cutaneous tumors: innocent bystander or maestro conductor?
    Biswas A; Richards JE; Massaro J; Mahalingam M
    Int J Dermatol; 2014 Jul; 53(7):806-11. PubMed ID: 23621615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
    Folpe AL; Veikkola T; Valtola R; Weiss SW
    Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Epithelioid Angiosarcoma of Bone with Robust Cell Cycle Progression and High Expression of SPARC: A Case Report and Review of the Literature.
    Mauzo SH; Yang M; Brown RE; Nguyen HN; Yan P
    Ann Clin Lab Sci; 2015; 45(3):360-5. PubMed ID: 26116605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling mysteries of the multifunctional protein SPARC.
    Fukunaga-Kalabis M; Herlyn M
    J Invest Dermatol; 2007 Nov; 127(11):2497-8. PubMed ID: 17934501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth.
    Prada F; Benedetti LG; Bravo AI; Alvarez MJ; Carbone C; Podhajcer OL
    J Invest Dermatol; 2007 Nov; 127(11):2618-28. PubMed ID: 17625595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved response to nab-paclitaxel compared with cremophor-solubilized paclitaxel is independent of secreted protein acidic and rich in cysteine expression in non-small cell lung cancer.
    Shao H; Tang H; Salavaggione OE; Yu C; Hylander B; Tan W; Repasky E; Adjei AA; Dy GK
    J Thorac Oncol; 2011 Jun; 6(6):998-1005. PubMed ID: 21532503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
    Hultgren TL; DiMaio DJ
    J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical fibroxanthoma with pseudoangiomatous features: a histological and immunohistochemical mimic of cutaneous angiosarcoma.
    Thum C; Husain EA; Mulholland K; Hornick JL; Brenn T
    Ann Diagn Pathol; 2013 Dec; 17(6):502-7. PubMed ID: 24080496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas.
    Pascual-Pasto G; Castillo-Ecija H; Unceta N; Aschero R; Resa-Pares C; Gómez-Caballero A; Vila-Ubach M; Muñoz-Aznar O; Suñol M; Burgueño V; Gomez-Gonzalez S; Sosnik A; Ibarra M; Schaiquevich P; de Álava E; Tirado OM; Mora J; Carcaboso AM
    J Control Release; 2022 Feb; 342():81-92. PubMed ID: 34974029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status.
    Desai NP; Trieu V; Hwang LY; Wu R; Soon-Shiong P; Gradishar WJ
    Anticancer Drugs; 2008 Oct; 19(9):899-909. PubMed ID: 18766004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials.
    Ormanns S; Haas M; Baechmann S; Altendorf-Hofmann A; Remold A; Quietzsch D; Clemens MR; Bentz M; Geissler M; Lambertz H; Kruger S; Kirchner T; Heinemann V; Boeck S
    Br J Cancer; 2016 Dec; 115(12):1520-1529. PubMed ID: 27802454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi sarcoma following postmastectomy lymphedema.
    Montero Pérez I; Rodríguez-Pazos L; Álvarez-Pérez A; Ferreirós MM; Aliste C; Suarez-Peñaranda JM; Toribio J
    J Cutan Pathol; 2015 Nov; 42(11):889-93. PubMed ID: 26264753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPARC promotes cathepsin B-mediated melanoma invasiveness through a collagen I/α2β1 integrin axis.
    Girotti MR; Fernández M; López JA; Camafeita E; Fernández EA; Albar JP; Benedetti LG; Valacco MP; Brekken RA; Podhajcer OL; Llera AS
    J Invest Dermatol; 2011 Dec; 131(12):2438-47. PubMed ID: 21850018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of CD163 in cutaneous spindle cell lesions.
    Pouryazdanparast P; Yu L; Cutlan JE; Olsen SH; Fullen DR; Ma L
    J Cutan Pathol; 2009 Aug; 36(8):859-64. PubMed ID: 19040468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
    Brown LF; Tognazzi K; Dvorak HF; Harrist TJ
    Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma.
    Brown LF; Dezube BJ; Tognazzi K; Dvorak HF; Yancopoulos GD
    Am J Pathol; 2000 Jun; 156(6):2179-83. PubMed ID: 10854238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravascular Kaposi's sarcoma - a hitherto unrecognized phenomenon.
    Luzar B; Antony F; Ramdial PK; Calonje E
    J Cutan Pathol; 2007 Nov; 34(11):861-4. PubMed ID: 17944727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential expression of SPARC in esophageal squamous cell carcinoma.
    Che Y; Luo A; Wang H; Qi J; Guo J; Liu Z
    Int J Mol Med; 2006 Jun; 17(6):1027-33. PubMed ID: 16685412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.
    Koukourakis MI; Giatromanolaki A; Brekken RA; Sivridis E; Gatter KC; Harris AL; Sage EH
    Cancer Res; 2003 Sep; 63(17):5376-80. PubMed ID: 14500371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.